News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
767,870 Results
Type
Article (74059)
Company Profile (666)
Press Release (693145)
Multimedia
Podcasts (110)
Webinars (14)
Section
Business (207454)
Career Advice (3303)
Deals (37305)
Drug Delivery (117)
Drug Development (85478)
Employer Resources (175)
FDA (17072)
Job Trends (16523)
News (358298)
Policy (35334)
Tag
Academia (2991)
Academic (2)
Accelerated approval (6)
Adcomms (26)
Allergies (94)
Alliances (51030)
ALS (98)
Alzheimer's disease (1477)
Antibody-drug conjugate (ADC) (140)
Approvals (17053)
Artificial intelligence (292)
Autoimmune disease (26)
Automation (16)
Bankruptcy (347)
Best Places to Work (12554)
BIOSECURE Act (21)
Biosimilars (114)
Biotechnology (457)
Bladder cancer (82)
Brain cancer (30)
Breast cancer (298)
Cancer (2387)
Cardiovascular disease (193)
Career advice (2792)
Career pathing (34)
CAR-T (172)
Cell therapy (472)
Cervical cancer (21)
Clinical research (69104)
Collaboration (897)
Company closure (1)
Compensation (567)
Complete response letters (26)
COVID-19 (2794)
CRISPR (46)
C-suite (266)
Cystic fibrosis (106)
Data (2284)
Decentralized trials (2)
Denatured (29)
Depression (52)
Diabetes (281)
Diagnostics (6849)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (41)
Drug discovery (131)
Drug pricing (117)
Drug shortages (30)
Duchenne muscular dystrophy (98)
Earnings (80581)
Editorial (43)
Employer branding (21)
Employer resources (150)
Events (121619)
Executive appointments (781)
FDA (18415)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (807)
Gene editing (116)
Generative AI (24)
Gene therapy (340)
GLP-1 (795)
Government (4930)
Grass and pollen (6)
Guidances (79)
Healthcare (20754)
Huntington's disease (22)
IgA nephropathy (29)
Immunology and inflammation (134)
Indications (30)
Infectious disease (2948)
Inflammatory bowel disease (154)
Inflation Reduction Act (11)
Influenza (55)
Intellectual property (101)
Interviews (619)
IPO (17634)
IRA (48)
Job creations (4464)
Job search strategy (2336)
Kidney cancer (10)
Labor market (37)
Layoffs (545)
Leadership (23)
Legal (8364)
Liver cancer (79)
Lung cancer (331)
Lymphoma (156)
Machine learning (7)
Management (62)
Manufacturing (334)
MASH (74)
Medical device (14499)
Medtech (14504)
Mergers & acquisitions (20272)
Metabolic disorders (741)
Multiple sclerosis (84)
NASH (21)
Neurodegenerative disease (105)
Neuropsychiatric disorders (32)
Neuroscience (2062)
NextGen: Class of 2025 (7537)
Non-profit (5048)
Now hiring (27)
Obesity (388)
Opinion (267)
Ovarian cancer (78)
Pain (101)
Pancreatic cancer (87)
Parkinson's disease (158)
Partnered (22)
Patents (250)
Patient recruitment (116)
Peanut (51)
People (63134)
Pharmaceutical (137)
Pharmacy benefit managers (19)
Phase I (21453)
Phase II (30129)
Phase III (22644)
Pipeline (1254)
Policy (160)
Postmarket research (3070)
Preclinical (9535)
Press Release (71)
Prostate cancer (113)
Psychedelics (36)
Radiopharmaceuticals (267)
Rare diseases (412)
Real estate (6893)
Recruiting (70)
Regulatory (24320)
Reports (39)
Research institute (2634)
Resumes & cover letters (512)
Rett syndrome (5)
RNA editing (5)
RSV (47)
Schizophrenia (79)
Series A (141)
Series B (92)
Service/supplier (27)
Sickle cell disease (57)
Special edition (17)
Spinal muscular atrophy (162)
Sponsored (31)
Startups (3866)
State (2)
Stomach cancer (13)
Supply chain (75)
Tariffs (43)
The Weekly (79)
Vaccines (753)
Venture capitalists (43)
Weight loss (263)
Women's health (32)
Worklife (20)
Date
Today (184)
Last 7 days (854)
Last 30 days (2825)
Last 365 days (34986)
2025 (11660)
2024 (37506)
2023 (42212)
2022 (53441)
2021 (58338)
2020 (57405)
2019 (51019)
2018 (38729)
2017 (35139)
2016 (34969)
2015 (40948)
2014 (34820)
2013 (32858)
2012 (32595)
2011 (32782)
2010 (31780)
Location
Africa (1066)
Alabama (59)
Alaska (7)
Arizona (223)
Arkansas (14)
Asia (45012)
Australia (8115)
California (6455)
Canada (2060)
China (561)
Colorado (282)
Connecticut (304)
Delaware (159)
Europe (104326)
Florida (947)
Georgia (221)
Hawaii (1)
Idaho (62)
Illinois (611)
India (30)
Indiana (332)
Iowa (11)
Japan (169)
Kansas (110)
Kentucky (28)
Louisiana (14)
Maine (70)
Maryland (966)
Massachusetts (4957)
Michigan (245)
Minnesota (424)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (66)
New Hampshire (70)
New Jersey (1829)
New Mexico (31)
New York (1836)
North Carolina (1128)
North Dakota (9)
Northern California (2772)
Ohio (220)
Oklahoma (15)
Oregon (48)
Pennsylvania (1431)
Puerto Rico (13)
Rhode Island (36)
South America (1412)
South Carolina (24)
South Dakota (1)
Southern California (2408)
Tennessee (105)
Texas (967)
United States (24758)
Utah (194)
Virginia (171)
Washington D.C. (69)
Washington State (607)
West Virginia (3)
Wisconsin (70)
767,870 Results for "university of new hampshire".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
HHS To Require Placebo-Controlled Trials for All New Vaccines in ‘Radical Departure’ From Past
The new policy, revealed by the Department of Health and Human Services on Wednesday, would make vaccines “less available and less affordable,” according to vaccine expert Paul Offit. It could also further complicate the picture for companies like Novavax.
May 1, 2025
·
3 min read
·
Heather McKenzie
Press Releases
Genprex Signs Exclusive Technology License Agreement with New York University Langone Health for the Treatment of Mesothelioma
April 29, 2025
·
8 min read
Layoffs
BMS Axes 516 More Employees in New Jersey
Bristol Myers Squibb has made significant cuts to its workforce since last year as part of a strategic reorganization aimed at saving $3.5 billion through 2027. The latest cuts in Lawrenceville, New Jersey, bring that area’s total number of disclosed cuts this year to 806.
May 5, 2025
·
2 min read
·
Angela Gabriel
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
Press Releases
Theralase Discovers New Mechanism of Action of Lead Drug
Theralase(R) Has Discovered a New Mechanism of Action in Its War on Cancer; Specifically, Ruvidar’s(TM) Ability to Inhibit DeUbiquitinating Enzymes, an Important Class of Enzymes Which Have Been Linked to Numerous Cancers and Neurogenerative Diseases
April 28, 2025
·
7 min read
Business
Alcami Completes cGMP Biostorage Expansion in New Hampshire
Alcami Corporation, a leading contract development and manufacturing organization, announced the completion of Phase III expansion of its cGMP biostorage facility located in Amherst, New Hampshire.
April 25, 2023
·
2 min read
Press Releases
Elicio Therapeutics Reports Inducement Grant to New Chief Strategy and Financial Officer and Other New Hires
April 17, 2025
·
2 min read
FDA
Makary Discusses Expedited Rare Disease Approvals Pathway, ‘Public Distrust’ in New Interview
In an interview with former
Fox News
journalist Megyn Kelly, FDA Commissioner Marty Makary introduced a new mechanism-driven pathway that could be leveraged by rare disease therapies while saying that autism could potentially be driven by certain environmental factors.
April 21, 2025
·
2 min read
·
Tristan Manalac
Biosimilars
Humira Biosimilars Gain Ground as Doctors Adjust and New Therapies Rise
AbbVie’s Humira was the top-selling drug in the world for many years. Now, its sales are eroding as doctors switch to biosimilars and new options enter the market.
March 26, 2025
·
6 min read
·
Annalee Armstrong
Press Releases
For Colon Cancer That No Longer Responds to Treatment, A New Drug Combination Offers Hope
April 24, 2025
·
5 min read
1 of 76,787
Next
